A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

The Department of Pharmaceuticals (DoP) received a 28.82 per cent boost, with Rs 5,268.72 crore allocated. The promotion of ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the company's top line.

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW/ - ...

A medical expert emphasized the critical need for the establishment of national guidelines and screening strategies especially for lung cancer tailored to Filipinos’ unique epidemiological landscape.

Fasenra, already approved for severe asthma, builds on this progress ... Fasenra are at the forefront of transforming treatment paradigms. AstraZeneca’s leadership and innovation in this space ...